{"id":"https://openalex.org/W4361891376","doi":"https://doi.org/10.1158/1078-0432.22486659","title":"Supplementary Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial","display_name":"Supplementary Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361891376","doi":"https://doi.org/10.1158/1078-0432.22486659"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22486659","doi":"https://doi.org/10.1158/1078-0432.22486659","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22486659","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Telaglenastat_Plus_Cabozantinib_or_Everolimus_for_Advanced_or_Metastatic_Renal_Cell_Carcinoma_An_Open-Label_Phase_I_Trial/22486659/1/files/39938244.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Telaglenastat_Plus_Cabozantinib_or_Everolimus_for_Advanced_or_Metastatic_Renal_Cell_Carcinoma_An_Open-Label_Phase_I_Trial/22486659/1/files/39938244.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Funda Meric-Bernstam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6816-6072","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058115259","display_name":"Nizar M. Tannir","orcid":"https://orcid.org/0000-0001-5559-8060","observed_orcids":["https://orcid.org/0000-0001-5559-8060"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nizar M. Tannir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038992904","display_name":"Othon Iliopoulos","orcid":"https://orcid.org/0000-0002-4444-6157","observed_orcids":["https://orcid.org/0000-0002-4444-6157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Othon Iliopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039517650","display_name":"Richard J. Lee","orcid":"https://orcid.org/0000-0001-9949-671X","observed_orcids":["https://orcid.org/0000-0001-9949-671X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard J. Lee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9949-671X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052487618","display_name":"Melinda L. Telli","orcid":"https://orcid.org/0000-0001-7993-1235","observed_orcids":["https://orcid.org/0000-0001-7993-1235"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melinda L. Telli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028169162","display_name":"Alice C. Fan","orcid":"https://orcid.org/0000-0002-4813-5444","observed_orcids":["https://orcid.org/0000-0002-4813-5444"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice C. Fan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4813-5444","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005537242","display_name":"Angela M. DeMichele","orcid":"https://orcid.org/0000-0003-1297-4251","observed_orcids":["https://orcid.org/0000-0003-1297-4251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela DeMichele","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1297-4251","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046123003","display_name":"Naomi Balzer Haas","orcid":"https://orcid.org/0000-0001-8907-7968","observed_orcids":["https://orcid.org/0000-0001-8907-7968"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naomi B. Haas","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8907-7968","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005718112","display_name":"Manish R. Patel","orcid":"https://orcid.org/0000-0001-6836-2364","observed_orcids":["https://orcid.org/0000-0001-6836-2364"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manish R. Patel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6836-2364","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065435809","display_name":"James J. Harding","orcid":"https://orcid.org/0000-0002-7029-4310","observed_orcids":["https://orcid.org/0000-0002-7029-4310","https://orcid.org/0000-0003-0766-9965"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Harding","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7029-4310","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091859782","display_name":"Martin Henner Voss","orcid":"https://orcid.org/0000-0003-0551-5807","observed_orcids":["https://orcid.org/0000-0003-0551-5807"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin H. Voss","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0551-5807","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015060656","display_name":"Taofeek Kunle Owonikoko","orcid":"https://orcid.org/0000-0002-7724-7728","observed_orcids":["https://orcid.org/0000-0002-7724-7728"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taofeek K. Owonikoko","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7724-7728","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035665916","display_name":"Bradley Curtis Carthon","orcid":"https://orcid.org/0000-0002-9176-8538","observed_orcids":["https://orcid.org/0000-0002-9176-8538"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bradley Carthon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031748968","display_name":"Ramaprasad Srinivasan","orcid":"https://orcid.org/0000-0001-6392-3169","observed_orcids":["https://orcid.org/0000-0001-6392-3169"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramaprasad Srinivasan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028472820","display_name":"Johanna C. Bendell","orcid":"https://orcid.org/0000-0001-9426-5891","observed_orcids":["https://orcid.org/0000-0001-9426-5891"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johanna C. Bendell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008883146","display_name":"Yonchu Jenkins","orcid":"https://orcid.org/0009-0000-1917-9248","observed_orcids":["https://orcid.org/0009-0000-1917-9248"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yonchu Jenkins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013695327","display_name":"Sam H. Whiting","orcid":"https://orcid.org/0009-0000-8736-0583","observed_orcids":["https://orcid.org/0009-0000-8736-0583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sam H. Whiting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109262452","display_name":"Keith William Orford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keith Orford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055304416","display_name":"Mark K. Bennett","orcid":"https://orcid.org/0000-0003-1046-1292","observed_orcids":["https://orcid.org/0000-0003-1046-1292"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark K. Bennett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037195922","display_name":"Todd Michael Bauer","orcid":"https://orcid.org/0000-0002-3078-5043","observed_orcids":["https://orcid.org/0000-0002-3078-5043"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Todd M. Bauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11297","display_name":"Ferroptosis and cancer prognosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telaglenastat","display_name":"telaglenastat","score":0.996999979019165},{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9850000143051147},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":1.0},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.8730000257492065},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6869999766349792},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.5379999876022339},{"id":"https://openalex.org/keywords/hif-1alpha-inhibition","display_name":"HIF-1\u03b1 inhibition","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.9733872413635254},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.8933838605880737},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.7857187986373901},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.6548425555229187},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6067314743995667},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.605803370475769},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47850146889686584},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3701540231704712},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3331463634967804}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22486659","doi":"https://doi.org/10.1158/1078-0432.22486659","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22486659","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Telaglenastat_Plus_Cabozantinib_or_Everolimus_for_Advanced_or_Metastatic_Renal_Cell_Carcinoma_An_Open-Label_Phase_I_Trial/22486659/1/files/39938244.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22486659.v1","doi":"https://doi.org/10.1158/1078-0432.22486659.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22486659.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22486659","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Data_from_Telaglenastat_Plus_Cabozantinib_or_Everolimus_for_Advanced_or_Metastatic_Renal_Cell_Carcinoma_An_Open-Label_Phase_I_Trial/22486659","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22486659","doi":"https://doi.org/10.1158/1078-0432.22486659","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22486659","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Telaglenastat_Plus_Cabozantinib_or_Everolimus_for_Advanced_or_Metastatic_Renal_Cell_Carcinoma_An_Open-Label_Phase_I_Trial/22486659/1/files/39938244.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361891376.pdf","grobid_xml":"https://content.openalex.org/works/W4361891376.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4211061257","https://openalex.org/W4361958889","https://openalex.org/W4294000513","https://openalex.org/W4280497867","https://openalex.org/W4361948078","https://openalex.org/W3168718184","https://openalex.org/W2415950182","https://openalex.org/W2237254160","https://openalex.org/W2899613191","https://openalex.org/W6885001090"],"abstract_inverted_index":{"Supplementary":[0],"Data":[1],"from":[2],"Telaglenastat":[3],"Plus":[4],"Cabozantinib":[5],"or":[6,10],"Everolimus":[7],"for":[8],"Advanced":[9],"Metastatic":[11],"Renal":[12],"Cell":[13],"Carcinoma:":[14],"An":[15],"Open-Label":[16],"Phase":[17],"I":[18],"Trial":[19]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}